Acute myeloid leukemia
Reference: Blood . 2017 Jan 26;129(4):424-447
Lymphoma
Reference: J Clin Oncol . 2014 Sep 20;32(27):3059-68
Plasma cell myeloma
Reference: Lancet Oncol . 2016 Aug;17(8):e328-e346
Myelodysplastic syndrome (MDS)
Reference:
Blood . 2006 Jul 15;108(2):419-25
Blood . 2019 Mar 7;133(10):1020-1030
Myeloproliferative neoplasm (MPN): CML
Reference: Leukemia . 2020 Apr;34(4):966-984
Myeloproliferative neoplasm (MPN): PV, ET, PMF
Reference:
Blood . 2013 Jun 6;121(23):4778-81
Blood . 2013 Aug 22;122(8):1395-8
Myelodysplastic syndrome/Myeloproliferative neoplasm (MDS/MPN)
Reference: Blood . 2015 Mar 19;125(12):1857-65
Aplastic anemia (AA)
Reference: N Engl J Med 2022; 386:11-23
Complete response:
Hb >= 10g/dL
ANC > 1000 /uL
Platelet > 100,000 /uL
Partial response
Between severe aplastic anemia and complete response
備註: Severe aplastic anemia
Reticulocyte < 60,000/uL
ANC < 500 /uL
Platelet < 20,000 /uL
Chronic lymphocytic leukemia (CLL)
Reference: Blood . 2018 Jun 21;131(25):2745-2760 (iwCLL )